Status:

TERMINATED

ThromboAblation in Acute Myocardial Infarction

Lead Sponsor:

KCRI

Collaborating Sponsors:

Spectranetics Corporation

Conditions:

ST Elevation Acute Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

1. Assess whether excimer laser coronary atherectomy (ELCA) before direct infarct-related artery (IRA) stenting results in improved reperfusion success in patients presenting with acute ST wave elevat...

Eligibility Criteria

Inclusion

  • Electrocardiographic inclusion criteria: (baseline 12-lead ECG recorded at 25 mm/second upon arrival at investigational center)
  • STEMI within 12 hours of symptom onset, with ≥ 2 mm ST segment elevation in two or more leads and minimum ≥ 3 mm ST segment elevation in one lead.
  • Angiographic inclusion criteria after crossing with guidewire:
  • IRA is a native coronary artery; and,
  • Reference vessel diameter 2.5 - 4.0 mm; and,
  • TIMI 0 or 1 flow with any TIMI thrombus grade; or,
  • TIMI 2 or 3 flow with TIMI thrombus grade 3 or greater

Exclusion

  • Patient unwilling or unable to give informed consent
  • Previous MI in the distribution of the current IRA
  • Previous CABG
  • Contraindications to PCI
  • allergy(s) to intended study medications
  • contraindicated for stent implantation
  • Active bleeding or coagulopathy
  • Patient in cardiogenic shock (\<90mmHg SBP and/or requiring IABP or vasopressors)
  • Known left ventricular ejection fraction (EF) \<30%
  • Fibrinolytic administered before PCI
  • Renal insufficiency (creatinine \>2.0mg/dl)
  • Current vitamin K antagonist therapy or known INR \>1.5
  • Known thrombocytopenia - platelets \<100,000 cell count
  • Patient has Left Bundle Branch Block (LBBB) or pacemaker rhythm
  • Known history of hemorrhagic stroke (CVA or TIA) \<2 years before screening
  • Known or suspected pregnancy
  • Current cancer disease
  • Comorbidity where survival is anticipated to be \<1 year.
  • No future patient cooperation expected
  • Patient is participating in another clinical study
  • Patient \<18 years of age

Key Trial Info

Start Date :

March 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00650975

Start Date

March 1 2008

End Date

January 1 2010

Last Update

January 20 2011

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Gornoslaskie Centrum Medyczne 3rd Dept of Cardiology

Katowice, Poland, 40-635

2

Jagiellonian University College of Medicine, Institute of Cardiology John Paul II Hospital

Krakow, Poland, 31-202

3

Department of Haemodynamics and Angiocardiography Medical College Jagiellonian University University Hospital in Krakow

Krakow, Poland, 31-501

4

University Hospital No. 1 1st Dept. of Cardiology

Poznan, Poland, 61-848